Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

por Chandran, Smita S., Ma, Jiaqi, Klatt, Martin G., Dündar, Friederike, Bandlamudi, Chaitanya, Razavi, Pedram, Wen, Hannah Y., Weigelt, Britta, Zumbo, Paul, Fu, Si Ning, Banks, Lauren B., Yi, Fei, Vercher, Enric, Etxeberria, Inaki, Bestman, Watchain D., Da Cruz Paula, Arnaud, Aricescu, Ilinca S., Drilon, Alexander, Betel, Doron, Scheinberg, David A., Baker, Brian M., Klebanoff, Christopher A.
Publicado 2022

Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7

por Parrish, Nicholas F., Wilen, Craig B., Banks, Lauren B., Iyer, Shilpa S., Pfaff, Jennifer M., Salazar-Gonzalez, Jesus F., Salazar, Maria G., Decker, Julie M., Parrish, Erica H., Berg, Anna, Hopper, Jennifer, Hora, Bhavna, Kumar, Amit, Mahlokozera, Tatenda, Yuan, Sally, Coleman, Charl, Vermeulen, Marion, Ding, Haitao, Ochsenbauer, Christina, Tilton, John C., Permar, Sallie R., Kappes, John C., Betts, Michael R., Busch, Michael P., Gao, Feng, Montefiori, David, Haynes, Barton F., Shaw, George M., Hahn, Beatrice H., Doms, Robert W.
Publicado 2012